NOCIL Ltd Q1 FY27 Revenue Up 20% To ₹403 Crore, PAT Jumps 61%

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
NOCIL Ltd Q1 FY27 Revenue Up 20% To ₹403 Crore, PAT Jumps 61%

NOCIL reported a strong Q1 FY27 with revenue up 20% to ₹403 crore and profit after tax (PAT) surging 61% to ₹28 crore. Despite sequential volume dips due to supply constraints, the company sees a positive outlook with capacity expansion and potential anti-dumping duties.

NOCIL Ltd Q1 FY27 Results

NOCIL Ltd's revenue for Q1 FY27 reached ₹ 403 crore, marking a 20% increase year-on-year. PAT grew 61% to ₹ 28 crore.

Reader Takeaway: Strong YoY growth driven by demand, but sequential volumes and costs face temporary pressure.

What just happened

NOCIL Ltd reported its financial results for the first quarter of FY27 (ending June 30, 2026). Key highlights include a 20% year-on-year (YoY) revenue growth to ₹ 403 crore. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) increased by 48% to ₹ 45 crore, with EBITDA margins improving by 210 basis points to 11.2%. Profit After Tax (PAT) saw a significant jump of 61% YoY, reaching ₹ 28 crore.

Why this matters

The strong YoY performance indicates a healthy demand environment and improving operational efficiency for NOCIL. The expansion in EBITDA margins and PAT suggests better profitability. The company's outlook remains positive, with guidance for FY27 revenue between ₹ 1,400 crore and ₹ 1,600 crore and an approximate 10% EBITDA margin.

The backstory

In Q1 FY26, NOCIL had reported a revenue of ₹ 336 crore and a PAT of ₹ 17 crore. The current quarter's performance shows a substantial recovery and growth from the previous fiscal year. The company is also investing in capacity expansion, with its new TDQ plant in Dahej nearing trial production.

What changes now

NOCIL's Q1 FY27 results reinforce its growth trajectory. The company is focusing on increasing its capacity and exploring measures like anti-dumping duties to protect its market position. Investors will be looking for the successful commercialization of the new TDQ plant and the impact of regulatory measures.

Risks to watch

Concerns include a sequential dip in volumes, attributed to temporary supply-side constraints and increased conversion costs due to higher freight rates and utility expenses. Promoter pledging, around 24% of the promoter holding, is also a point to monitor for governance.

Peer comparison

While specific peer data for Q1 FY27 is not provided in the filing, NOCIL operates in the rubber chemicals sector. Companies in this segment often face similar challenges related to raw material costs, geopolitical factors impacting logistics, and regulatory measures like anti-dumping duties.

Context metrics (time-bound)

  • Revenue (Q1 FY27): ₹ 403 crore (up 20% YoY)
  • PAT (Q1 FY27): ₹ 28 crore (up 61% YoY)
  • EBITDA Margin (Q1 FY27): 11.2% (up 210 bps YoY)
  • Volumes (Q1 FY27): Up 9% YoY, down 3% sequentially.
  • TDQ Plant: Trial production started, commercial supply expected by Q4 FY27.
  • Promoter Pledging: ~24% of promoter holding.

What to track next

Investors should monitor the commencement of commercial supplies from the Dahej TDQ plant, the final government decision on the ADD for Pilflex 13, and any changes in the promoter pledging levels. The company's ability to manage costs amidst supply chain pressures will also be crucial.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.